← feed

Is NCT03318562 results overdue?

Yes — results are overdue. Primary completion was 2018-07-05; the FDAAA-801 reporting deadline (2019-07-05) passed 2589 days ago and no results are posted on ClinicalTrials.gov.

A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC

NCT IDNCT03318562 ↗
SponsorEffector Therapeutics (INDUSTRY)
PhasePHASE2
StatusTERMINATED
Primary completion2018-07-05 (ACTUAL)
Reporting deadline2019-07-05 (completion + 365d)
Days overdue2589
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 ca5ddd8b7b0cce63… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03318562. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →